The intention behind the design of a metal complex is quite crucial for its development
towards a particular application. Transition metal complexes have tremendously become …

This review outlines research on the development of ruthenium complexes containing
acylthiourea ligands with potential antitumor activity, which have been leveraged in recent …

The popularity of RAPTA-C in in vivo studies has steered the way for complexes of the type
[Ru (η 6-arene)(X)(Y)(Z)] n+ (where X, Y and Z are monodentate ligands) to be developed …

Six different acylthiourea ligands (L1–L6) and their corresponding Ru (II)-p-cymene
complexes (P1–P6) were designed to explore the structure–activity relationship of the …

Metallodrugs have a central role in the treatment and diagnosis of diseases. To overcome
potential toxicity and equip metal-based anticancer agents with biological activity, the choice …

Platinum-based anticancer drugs are most likely the most successful group of bioinorganic
compounds. Their apparent disadvantages have led to the development of anticancer …

Ruthenium compounds are promising anticancer candidates owing to their lower side-
effects and encouraging activities against resistant tumors. Half-sandwich piano-stool type …

In this work, two thiourea ligands bearing a phosphine group in one arm and in the other a
phenyl group (T2) or 3, 5-di-CF3 substituted phenyl ring (T1) have been prepared and their …

Here we report the crystallization of the tris (nitrate-O, O')-bis (1, 10-phenanthroline-N, N')-
neodymium (III) complex by the slow solvent evaporation method. Structural, electronic …

Abstract A dichloro-bis (theophylline)-copper (II) complex, named [Cu (theo) 2 Cl 2], was
synthesized, with the aim to characterize its physicochemical and pharmacological …